{"filings":[{"id":112992,"accession_number":"0001493152-26-003615","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2026-01-26T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Daxor raises ~$8.1M in registered direct offering of 765,958 shares at $11.75/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold 765,958 shares at $11.75 per share for net proceeds of approx. $8,142,006 after fees.","Offering closed January 26, 2026; Lake Street Capital Markets acted as placement agent.","Shares registered under shelf registration statement on Form N-2 (File No. 333-281622) effective Jan 20, 2026.","Company did not specify use of proceeds; typical for working capital and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":112991,"accession_number":"0001493152-26-003302","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Daxor files 8-K with investor presentation; no details available from provided text","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Daxor Corporation issued a regulatory filing attaching an investor presentation on January 23, 2026.","Exhibit 99.1 is the investor presentation, but its content was not included in the text provided for analysis.","No financial results, guidance, or material developments are available from this filing.","Confidence is low due to absence of exhibit content."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145960,"accession_number":"0001641172-25-022513","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Daxor receives FDA 510(k) clearance for next-gen blood volume analyzer","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["FDA 510(k) clearance (K251087) for patent-pending rapid, hand-held BVA device.","Device provides results 3x faster, weighs 7 lbs, delivers lab-grade precision.","Clinical data: BVA-guided care reduced heart failure mortality by 86% (p<0.001), ICU mortality by 66%.","Over 75,000 tests shipped; developed under U.S. Army/DHA contract.","Management expects high demand driven by speed, simplicity, precision."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":145959,"accession_number":"0001641172-25-017303","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Daxor reports annual meeting voting results; all director nominees elected, auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected; votes for ranged from 3,473,576 to 3,493,651.","Ratification of Bush & Associates as independent auditor approved with 3,494,574 for, 100 against, 876 abstain.","Annual meeting held June 24, 2025; no other material matters voted upon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214713,"accession_number":"0001493152-24-028308","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2024-07-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Daxor holds annual meeting; re-elects six directors, ratifies auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected with over 3.5M votes for each; no new directors.","Citrin Cooperman LLP ratified as independent auditor with 4.76M votes for, 28.4K against.","Broker non-votes of 1.23M shares on director elections due to non-discretionary items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233853,"accession_number":"0001493152-24-022735","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2024-06-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Daxor resolves Nasdaq audit committee deficiency with appointment of Caleb DesRosiers","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Daxor on May 30, 2024 of non-compliance with audit committee rule due to death of James A. Lombard.","Company appointed Caleb DesRosiers to audit committee; Nasdaq staff determined compliance and closed the matter.","No further action required; listing continues on Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251830,"accession_number":"0001493152-24-011110","cik":27367,"company_name":"DAXOR CORP","ticker":"DXR","form_type":"8-K","filed_at":"2024-03-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Daxor acquires worldwide rights to Volumex, Megatope, and Glofil from Iso-Tex Diagnostics","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["No upfront payment; seller-financed with monthly installments starting after manufacturing transition in 6–9 months.","Deal expected to be immediately accretive and cash flow positive due to higher margins from in-house production.","Glofil (GFR diagnostic) adds recurring revenue stream and cross-selling opportunity to existing hospital customers.","Volumex and Megatope radiopharmaceuticals for blood volume analysis will be produced at Daxor's Oak Ridge facility.","Transaction subject to customary closing conditions including applicable regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":66200000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}